Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 20838415)

1.

Delivering nanomedicine to solid tumors.

Jain RK, Stylianopoulos T.

Nat Rev Clin Oncol. 2010 Nov;7(11):653-64. doi: 10.1038/nrclinonc.2010.139. Epub 2010 Sep 14. Review.

2.

Multistage nanoparticles for improved delivery into tumor tissue.

Stylianopoulos T, Wong C, Bawendi MG, Jain RK, Fukumura D.

Methods Enzymol. 2012;508:109-30. doi: 10.1016/B978-0-12-391860-4.00006-9.

3.

Advances and advantages of nanomedicine in the pharmacological targeting of hyaluronan-CD44 interactions and signaling in cancer.

Skandalis SS, Gialeli C, Theocharis AD, Karamanos NK.

Adv Cancer Res. 2014;123:277-317. doi: 10.1016/B978-0-12-800092-2.00011-3. Review.

PMID:
25081534
4.

Nanoparticle delivery of cancer drugs.

Wang AZ, Langer R, Farokhzad OC.

Annu Rev Med. 2012;63:185-98. doi: 10.1146/annurev-med-040210-162544. Epub 2011 Sep 1. Review.

PMID:
21888516
5.

Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies.

Chauhan VP, Stylianopoulos T, Boucher Y, Jain RK.

Annu Rev Chem Biomol Eng. 2011;2:281-98. doi: 10.1146/annurev-chembioeng-061010-114300. Review.

PMID:
22432620
6.

Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.

Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, Barry ST, Gabizon A, Grodzinski P, Blakey DC.

Cancer Res. 2013 Apr 15;73(8):2412-7. doi: 10.1158/0008-5472.CAN-12-4561. Epub 2013 Feb 19.

7.

Multistage nanoparticle delivery system for deep penetration into tumor tissue.

Wong C, Stylianopoulos T, Cui J, Martin J, Chauhan VP, Jiang W, Popovic Z, Jain RK, Bawendi MG, Fukumura D.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2426-31. doi: 10.1073/pnas.1018382108. Epub 2011 Jan 18. Erratum in: Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6336.

8.

Drug delivery and transport to solid tumors.

Jang SH, Wientjes MG, Lu D, Au JL.

Pharm Res. 2003 Sep;20(9):1337-50. Review.

PMID:
14567626
9.

Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.

Pridgen EM, Langer R, Farokhzad OC.

Nanomedicine (Lond). 2007 Oct;2(5):669-80. Review.

PMID:
17976029
10.

Simulation of transport and extravasation of nanoparticles in tumors which exhibit enhanced permeability and retention effect.

Podduturi VP, MagaƱa IB, O'Neal DP, Derosa PA.

Comput Methods Programs Biomed. 2013 Oct;112(1):58-68. doi: 10.1016/j.cmpb.2013.06.011. Epub 2013 Jul 18.

PMID:
23871689
11.
12.

Tumor physiology and delivery of nanopharmaceuticals.

Campbell RB.

Anticancer Agents Med Chem. 2006 Nov;6(6):503-12. Review.

PMID:
17100555
13.

Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

Shapira A, Livney YD, Broxterman HJ, Assaraf YG.

Drug Resist Updat. 2011 Jun;14(3):150-63. doi: 10.1016/j.drup.2011.01.003. Epub 2011 Feb 16. Review.

PMID:
21330184
14.

Vascular and interstitial barriers to delivery of therapeutic agents in tumors.

Jain RK.

Cancer Metastasis Rev. 1990 Nov;9(3):253-66. Review.

PMID:
2292138
15.

Application of nanotechnology in biomedicine.

Navalakhe RM, Nandedkar TD.

Indian J Exp Biol. 2007 Feb;45(2):160-5. Review.

PMID:
17375555
16.

Disposition of nanoparticle-based delivery system via inner ear administration.

Chen G, Zhang X, Yang F, Mu L.

Curr Drug Metab. 2010 Dec;11(10):886-97. Review.

PMID:
21208174
17.

State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines.

Dawidczyk CM, Kim C, Park JH, Russell LM, Lee KH, Pomper MG, Searson PC.

J Control Release. 2014 Aug 10;187:133-44. doi: 10.1016/j.jconrel.2014.05.036. Epub 2014 May 27. Review.

PMID:
24874289
18.

Therapeutic nanoparticles for drug delivery in cancer.

Cho K, Wang X, Nie S, Chen ZG, Shin DM.

Clin Cancer Res. 2008 Mar 1;14(5):1310-6. doi: 10.1158/1078-0432.CCR-07-1441. Review.

19.

Nanotechnology platforms; an innovative approach to brain tumor therapy.

Nair BG, Varghese SH, Nair R, Yoshida Y, Maekawa T, Kumar DS.

Med Chem. 2011 Sep;7(5):488-503. Review.

PMID:
21801148
20.

Role of integrated cancer nanomedicine in overcoming drug resistance.

Iyer AK, Singh A, Ganta S, Amiji MM.

Adv Drug Deliv Rev. 2013 Nov;65(13-14):1784-802. doi: 10.1016/j.addr.2013.07.012. Epub 2013 Jul 21. Review.

PMID:
23880506
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk